The market cap is under $10m! Only can lose at this level if the company completely shuts downs, fires everyone, can’t sell patents, and abandons p1/2 that they worked so hard to get (and is completed fronted by hospitals and funded by NIH).
Anything under $100m market cap is a buy with CURRENT known info.